相关实验视频

Updated: Feb 17, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

在IBD患者中,Clostridioides difficile感染的诊断挑战和治疗方法

Asghar Ali¹, Khalid I AlHussaini²

¹Clinical Biochemistry Lab, Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India.

Frontiers in microbiology

|February 16, 2026

概括

在炎症性肠病 (IBD) 患者中诊断和管理Clostridioides difficile感染 (CDI) 是复杂的. 个性化方法整合准确的诊断,向治疗和预防对于更好的结果至关重要.

科学领域:

胃肠病学胃肠病学
传染性疾病传染性疾病
微生物学微生物学

背景情况:

艰难菌感染 (CDI) 在炎症性肠病 (IBD) 患者中提出了重大挑战.
重叠的症状,诊断困难和独特的治疗需求使IBD中CDI管理变得复杂.
被破坏的肠道微生物群和免疫失调是CDI-IBD相互作用的关键因素.

研究的目的:

审查目前关于IBD患者CDI的诊断和管理的证据.
分析IBD中CDI的诊断方法,治疗策略和预防干预措施.
突出最近的进展及其在该患者群体中的临床适用性.

主要方法:

对IBD中CDI的现有文献进行批判性审查.
对研究的分析,重点是诊断工具,治疗选择和预防.
强调最近的进展和临床相关性.

主要成果:

在IBD中诊断CDI是具有挑战性的,因为目前的测试具有类似的症状和局限性.
新兴的诊断工具显示了提高准确性和速度的希望.
标准疗法 (抗生素,FMT) 需要个性化应用,考虑到免疫抑制和药物相互作用.
治疗成功受到疾病严重程度和抗菌素耐药性的影响.
预防策略,如抗菌药物管理和益生菌,可能会降低CDI发病率.

结论:

对IBD中CDI的个性化管理策略至关重要,包括准确的诊断,有针对性的治疗和预防.
在理解宿主微生物群相互作用和优化个性化治疗方面,仍然存在知识差距.
未来的研究应该优先考虑诊断精度和个性化医疗,以改善患者的治疗结果.

关键词:

抗菌药物反症 (AMR) 是一种在CDI中,CDI是最重要的.在FMT和FMT中使用.抗微生物药物是一种抗菌药物.免疫调节失调免疫调节失调我们的微生物群.益生菌是一种益生菌.治疗疗法治疗疗法治疗疗法

更多相关视频

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...